Comparison of long-term outcomes between spousal transplants and other living unrelated donor transplants: single-center experience

Nephron Clin Pract. 2009;113(4):c241-9. doi: 10.1159/000235248. Epub 2009 Aug 15.

Abstract

Background/aims: The greater use of living unrelated donors (LUDs) as kidney donors is a worldwide trend in the current era of organ shortage, and spouses are an important source of LUDs. This study was to compare the long-term outcomes of spousal donor grafts with other LUD grafts.

Methods: Among 445 LUD grafts, 77 were spouses and 368 were other LUDs. The clinical characteristics and long-term survival rates for spousal transplants were compared with those for other LUD transplants, and risk factors affecting graft survival were assessed.

Results: Spousal donors had a significantly higher average number of human leukocyte antigen (HLA) mismatches (4.2 vs. 3.4, p < 0.001) and were older (41 vs. 33 years, p < 0.001) than LUDs. The 10-year survival rates for spousal donor grafts were 60.6%, similar to those for LUD grafts (58.5%, p = 0.61). The 10-year biopsy-proven acute rejection-free survival rates (85.5 vs. 89.6%, p = 0.45) and patient survival rates were also similar (84.3 vs. 79.6%, p = 0.35). The degree of HLA mismatching, the spousal donor type or donor age did not affect the graft survival.

Conclusion: Renal transplants from spousal donors show similar long-term outcomes to those from better HLA-matched and younger LUDs.

Publication types

  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Acute Kidney Injury / mortality*
  • Acute Kidney Injury / rehabilitation*
  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Kidney Transplantation / classification
  • Kidney Transplantation / mortality*
  • Korea / epidemiology
  • Living Donors / classification
  • Living Donors / statistics & numerical data*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Prevalence
  • Risk Assessment
  • Risk Factors
  • Spouses / statistics & numerical data*
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome
  • Young Adult